Riboflavin-LSD1 axis participates in the in vivo tumor-associated macrophage morphology in human colorectal liver metastases.

Journal Information

Full Title: Cancer Immunol Immunother

Abbreviation: Cancer Immunol Immunother

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Competing interestsThe authors declare that they have no competing interests. Ethical approval and consent to participateThe study protocol was submitted to the international clinical trial registry (ClinicalTrials.gov Registration Number NCT03888638) and approved by the IRCCS Humanitas Research Hospital Ethical Committee (Registration Number 282/19). Consent for publicationAll authors have read the manuscript and agree to publish. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"This study was supported by the Italian Ministry of Health Grant Number RF-2018-12367150."

Evidence found in paper:

"The study included fourteen patients who underwent surgery at the IRCCS Humanitas Research Hospital between 2020 and 2022 for CLM (Table ). The study protocol, submitted to the international clinical trial registry (ClinicalTrials.gov registration number NCT03888638), was designed to identify macrophage-related morphological features associated with distinct clinical outcomes. Written informed consent was obtained from each patient included in the study. The study protocol was in accordance with the ethical guidelines established in the 1975 Declaration of Helsinki and compliant with the procedures of the local ethical committee of the IRCCS Humanitas Research Hospital (registration number 282/19). Declarations: Competing interestsThe authors declare that they have no competing interests.: Ethical approval and consent to participateThe study protocol was submitted to the international clinical trial registry (ClinicalTrials.gov Registration Number NCT03888638) and approved by the IRCCS Humanitas Research Hospital Ethical Committee (Registration Number 282/19).: Consent for publicationAll authors have read the manuscript and agree to publish. Ethical approval and consent to participate: The study protocol was submitted to the international clinical trial registry (ClinicalTrials.gov Registration Number NCT03888638) and approved by the IRCCS Humanitas Research Hospital Ethical Committee (Registration Number 282/19)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025